Page last updated: 2024-09-03

methylthio-adp and phosphocreatine

methylthio-adp has been researched along with phosphocreatine in 1 studies

Compound Research Comparison

Studies (methylthio-adp)	Trials (methylthio-adp)	Recent Studies (post-2010) (methylthio-adp)	Studies (phosphocreatine)	Trials (phosphocreatine)	Recent Studies (post-2010) (phosphocreatine)
146	2	43	7,475	329	575

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Järv, J; Sak, K	1

Other Studies

1 other study(ies) available for methylthio-adp and phosphocreatine

Article	Year
Adenosine triphosphate is full antagonist at human P2Y(1) purinoceptors. Neuroscience letters, 2000, Apr-28, Volume: 284, Issue:3 Topics: Adenosine Diphosphate; Adenosine Triphosphate; Cell Line; Creatine Kinase; Dose-Response Relationship, Drug; Half-Life; Humans; Inositol Phosphates; Phosphocreatine; Phosphorylation; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Thionucleotides	2000

Article

Year

Adenosine triphosphate is full antagonist at human P2Y(1) purinoceptors.

Neuroscience letters, 2000, Apr-28, Volume: 284, Issue:3

Topics: Adenosine Diphosphate; Adenosine Triphosphate; Cell Line; Creatine Kinase; Dose-Response Relationship, Drug; Half-Life; Humans; Inositol Phosphates; Phosphocreatine; Phosphorylation; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; Thionucleotides

2000